Stein, Peter
United States Food and Drug Administration
4 papers on CoChat
Most cited papers
- Verified
Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine
Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,248
- Verified
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Rosenstock, J., Brazg, R., Andryuk, P. J., Lu, K., & Stein, P. (2006) · Clinical Therapeutics
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 514
- Verified
Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective
Dunn, B., Stein, P., & Cavazzoni, P. (2021) · JAMA Internal Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 246
- Verified
An Appropriate Use of Accelerated Approval — Aducanumab for Alzheimer’s Disease
Dunn, B., Stein, P., Temple, R., & Cavazzoni, P. (2021) · New England Journal of Medicine
Alzheimer's disease research and treatmentsBiomedical Ethics and Regulation
Cited by 42
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free